IFF Health Sciences has expanded its animal health portfolio with the introduction of HOWARU® Pet PureStrong™, a probiotic developed specifically for dogs and built around a strain isolated from the microbiome of healthy canines. This “derived from dogs, for dogs” approach reflects the growing shift towards species‑native microbial solutions that respect the natural ecology of each animal.
HOWARU® Pet PureStrong™ has been formulated to deliver superior compatibility in canine applications, offering stability across multiple formats and low‑dose efficacy, making it suitable for functional treats, supplements and complete diets. According to IFF, the strain demonstrates proven benefits for digestive health and resilience, supporting dogs during dietary transitions and contributing to improved stool quality and consistency.
Beyond gastrointestinal support, the probiotic also promotes overall wellness, helping to reinforce immune function and contributing to more “healthy days” for pets. Its technical profile positions it as a high‑value ingredient for manufacturers seeking science‑backed differentiation in an increasingly competitive pet nutrition market.
With HOWARU® Pet PureStrong™, IFF strengthens its leadership in advanced probiotics for companion animals, delivering innovation grounded in microbiome science and tailored to the specific needs of dogs.
More information here: http://spr.ly/6045B6WhGN
